The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
B

Buchholz

TL2 Member · Pisa, IT

Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.

Joined 6 May 2025 · last posted 1d

90Posts here
5Topics
0Solutions
1.1kLikes received
1.9kLikes given
22Badges
235Days visited
4.5kPosts read

Most-liked posts

  • Second pass at: Retatrutide dose escalation in the published trials Started this topic · Compounds › Retatrutide · 14 Jul 2024 · 48 likes Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. Two things I would like…
  • About the Bloodwork category Replied, post #3 · Clinical › Bloodwork · 26 Jan 2026 · 32 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
  • Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #29 · Compounds › Oral incretins · 26 Dec 2024 · 32 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
  • Coming back to: Training through a dose escalation week Replied, post #20 · Nutrition & Training › Resistance training · 2 Feb 2026 · 30 likes Post #19 is right about the mechanism and I think understates the practical bit. Cardio and resistance: the interaction between energy-intense cardiovascular training…
  • Absence of evidence and evidence of absence Replied, post #12 · Research Methods › Statistics · 7 Jan 2026 · 30 likes Post #8 and I disagree about the size of the effect, not about the direction. Confounding: a third variable explains an apparent association. In randomised data,…
  • Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #10 · Compounds › Semaglutide · 18 Nov 2025 · 30 likes On post #8 — agreed on the reasoning, with one qualification. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation…

Where this member posts

CategoryPostsShare
Compounds1314%
Evidence1112%
Practice1011%
Analytics910%
Meta67%
Start Here44%

Badges earned, in order

BadgeTierGranted
Basic Userbronze7 May 2025
Read the Guidelinesbronze10 May 2025
Welcomebronze11 May 2025
First Linkbronze13 May 2025
First Replybronze14 May 2025
First Topicbronze21 May 2025
Asked Wellbronze27 May 2025
First Quotebronze1 Jun 2025
Memberbronze5 Jun 2025
First Tagbronze20 Jun 2025
Generousbronze17 Jul 2025
Popular Linksilver2 Aug 2025
Sourcedbronze27 Aug 2025
Good Postsilver28 Aug 2025
Readerbronze1 Sep 2025
Nice Postbronze11 Sep 2025
Thank Yousilver12 Sep 2025
Good Topicsilver6 Oct 2025
Editorbronze8 Oct 2025
Nice Topicbronze15 Oct 2025
Consistently Generoussilver28 Oct 2025
Anniversarysilver6 May 2026